Skip to main content
. 2021 Oct 27;7:315. doi: 10.1038/s41420-021-00703-w

Fig. 3. RBM15 promotes tumor growth and migration/invasion capability of HCC cells in vitro.

Fig. 3

a, b Negative control or siRNA (si-RBM15#1 and #2) was transfected into HCC-LM3 (a) and MHCC97H (b), respectively. The efficiency of knockdown was tested by western blotting and the proliferation capacities of HCC cells were detected by CCK-8 and colony-formation assays (***p < 0.001, ****p < 0.0001; two-way ANOVA and t test); c, d EdU assays were applied to compare the proliferation abilities of HCC-LM3 (c) and MHCC97H cells (d) (scale bar, 200 μm); bar charts showed the percentage of cells in S phage based on the results of EdU assays (**p < 0.01; t test); e, f wound-healing assays were performed to compared the migration capabilities of HCC-LM3 (e) and MHCC97H (f) cells (scale bars, 200 μm); the percentage of healed area were quantified by bar charts (****p < 0.0001; t test); g, h transwell assays were applied to detect the migration and invasion abilities of HCC-LM3 (g) and MHCC97H (h) cells after silencing RBM15 (scale bars, 200 μm); bar charts showed the relative count of two groups of HCC cells, which passed through the chamber membranes when referred to negative control groups (****p < 0.0001; t test); The data are presented as mean ± SD.